IXEMPRA J Code: J9207

Drug & Product Overview

HCPCS Descriptor Injection, ixabepilone, 1 mg

HCPCS Added Date January 1, 2009

Manufacturer R-pharm Us

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Kit

About IXEMPRA

Ixempra is a medication aligned to the HCPCS J Code: J9207 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intravenous route and manufactured by R-pharm Us.

According to CMS Drug Use Information: This medication is used to treat advanced breast cancer. Ixabepilone is a chemotherapy drug that works to slow or stop cancer cell growth.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
70020-1910-01	Ixempra	R-Pharm US Operating, LLC	15	15 MG
70020-1911-01	Ixempra	R-Pharm US Operating, LLC	45	45 MG

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

IXEMPRA Pricing & Reimbursement

J9207 Private Payer Reimbursement

$144.82 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

IXEMPRA Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 54.45%

Avg. Days to File 16.2days

Avg. Days to Pay 25.7days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9207 claims analytics on FocalPoint →

IXEMPRA CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

JW / JZ modifiers apply

CMS has identified Ixempra (J9207) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

IXEMPRA Medically Unlikely Edits (MUE)

The most billing units of J9207 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.

Practitioner Office & Hospital Outpatient

90 units / day

= 90 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

IXEMPRA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

metastatic or locally advanced breast cancer

Frequently Asked Questions

Is there an available Ixempra billing and coding guide?

Our team has not identified a manufacturer-published source of billing and coding information for IXEMPRA.

Are there any available Ixempra patient assistance programs?

IXEMPRA patient assistance information can be found through R-Pharm US. Visit Here →

Where can I find Ixempra prescribing information?

IXEMPRA prescribing information can be found at the link below: Visit Here →

Where can I find Ixempra side effect information?

Information regarding IXEMPRA's side effects can be found at MedlinePlus Visit Here →

Does billing IXEMPRA require JZ/JW wastage modifiers?

CMS has identified IXEMPRA(J9207) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.